LIRAGLUTIDE (Victoza®)
Clinical Indication
Type 2 diabetes
Comments
For patients unable to tolerate lixisenatide. Conditional on prescriber being trained to select and train patients – Use in conjunction with Updated NICE Clinical Guideline
Date of classification
June 2015
Green
Medicines which could be started in any health care setting and do not require oversight by a specialist and which primary care would have full responsibility for prescribing and monitoring.